Schering AG, located in Berlin, Germany, has recently purchased Partek GS to analyze exon data. Schering specializes in the research and drug discovery of issues relating to gynecology, andrology, and oncology.
Partek GS is designed to import, analyze, and visualize high-dimensional genomic data. It is Affymetrix GeneChip-compatibleTM for exon, gene expression, chromosomal copy number, and tiling array analysis. Partek GS can analyze SNP data as well.
Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.
CONTACT INFORMATION: Marketing Communications Partek Incorporated 314-878-2329 314-275-8453 www.partek.com